Answers from the Lab

In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, invited Min-Han Tan, M.B.B.S., FRCP, Ph.D., founding CEO and medical director of Lucence, to discuss liquid biopsy cancer testing. Mayo Clinic Laboratories and Lucence recently announced a collaboration to expand access to this cutting-edge cancer test that is designed to detect clinically relevant biomarkers in ctDNA and ctRNA.

During their conversation, Dr. Morice and Dr. Tan explore:

• Inspiration for developing the liquid biopsy.
• Features that differentiate LiquidHALLMARK® from existing cancer tests.
• Patients who will benefit from the test and how an oncologist might use the results.
• The future potential of liquid biopsy advancements.